Screener
Eli Lilly LLY Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Eli Lilly in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Eli Lilly’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 2:40 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000059478-26-000081
| Assets | June 30, 2026 / (Unaudited) | December 31, 2025 |
|---|---|---|
| Other intangibles, net | 18,110 | 6,521 |
| Deferred tax assets | 10,028 | 9,959 |
| Property and equipment, net of accumulated depreciation of $13,103 (2026) and $12,560 (2025) | 29,286 | 24,675 |
| Other noncurrent assets | 7,482 | 6,992 |
| Total assets | $142,283 | $112,476 |
| Liabilities and Equity | ||
| Current Liabilities | ||
| Short-term borrowings and current maturities of long-term debt | $7,050 | $1,635 |
Item 1. Financial Statements
FAQ
- What is Eli Lilly's other non-current assets?
- Eli Lilly (LLY) reported other non-current assets of $7.48B in Q2 2026.
- How has Eli Lilly's other non-current assets changed year-over-year?
- Eli Lilly's other non-current assets increased by 20.2% year-over-year, from $6.23B to $7.48B.
- What is the long-term trend for Eli Lilly's other non-current assets?
- Over 5 years (2020 to 2025), Eli Lilly's other non-current assets has grown at a 15.0% compound annual growth rate (CAGR), from $3.48B to $6.99B.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Eli Lilly's other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude